These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27288325)

  • 1. When Morphology Meets Somatic Mutations: The New Possible Scenario in Thyroid Fine-Needle Aspiration.
    Rossi ED; Schmitt F
    Acta Cytol; 2016; 60(2):93-6. PubMed ID: 27288325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphological features that can predict BRAF
    Rossi ED; Bizzarro T; Martini M; Capodimonti S; Cenci T; Fadda G; Schmitt F; Larocca LM
    Cytopathology; 2017 Feb; 28(1):55-64. PubMed ID: 27256275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncommon BRAF mutations in the follicular variant of thyroid papillary carcinoma: New insights.
    Rossi ED; Martini M; Bizzarro T; Capodimonti S; Cenci T; Lombardi CP; Pontecorvi A; Fadda G; Larocca LM
    Cancer Cytopathol; 2015 Oct; 123(10):593-602. PubMed ID: 26230187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of monocarboxylate transporters in thyroid carcinoma can be associated with the morphological features of BRAF
    Rossi ED; Bizzarro T; Granja S; Martini M; Capodimonti S; Luca E; Fadda G; Lombardi CP; Pontecorvi A; Larocca LM; Baltazar F; Schmitt F
    Endocrine; 2017 May; 56(2):379-387. PubMed ID: 27484771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience.
    Rossi ED; Bizzarro T; Martini M; Capodimonti S; Fadda G; Larocca LM; Schmitt F
    Cancer Cytopathol; 2014 Dec; 122(12):883-91. PubMed ID: 25156883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of BRAF c.1799T > A (p.V600E) mutation using residual routine fine-needle aspiration specimens of papillary thyroid carcinoma.
    Zhao H; Zhang ZH; Zhou B; Xiao T; Pan QJ; Guo HQ
    Diagn Cytopathol; 2015 Oct; 43(10):786-90. PubMed ID: 26152656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of the BRAF(V600E) mutation in fine needle aspiration cytology of thyroid papillary microcarcinoma cells selected by manual macrodissection: an easy tool to improve the preoperative diagnosis.
    Marchetti I; Iervasi G; Mazzanti CM; Lessi F; Tomei S; Naccarato AG; Aretini P; Alberti B; Di Coscio G; Bevilacqua G
    Thyroid; 2012 Mar; 22(3):292-8. PubMed ID: 22181337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRAF analysis by fine needle aspiration biopsy of thyroid nodules improves preoperative identification of papillary thyroid carcinoma and represents a prognostic factor. A mono-institutional experience.
    Pelizzo MR; Boschin IM; Barollo S; Pennelli G; Toniato A; Zambonin L; Vianello F; Piotto A; Ide EC; Pagetta C; Sorgato N; Torresan F; Girelli ME; Nacamulli D; Mantero F; Mian C
    Clin Chem Lab Med; 2011 Feb; 49(2):325-9. PubMed ID: 21175381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAF mutation testing of thyroid fine-needle aspiration specimens enhances the predictability of malignancy in thyroid follicular lesions of undetermined significance.
    Adeniran AJ; Hui P; Chhieng DC; Prasad ML; Schofield K; Theoharis C
    Acta Cytol; 2011; 55(6):570-5. PubMed ID: 22156468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid Fine Needle Aspiration, the Bethesda System, and the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Association and Prediction for Biopsy.
    Galán-García ME; Martínez-Martin MS; Araujo-Ruano EJ; Loro-Ferrer JF; Saavedra-Santana P; Salido-Ruiz E; Cabrera-Galván JJ
    Acta Cytol; 2023; 67(4):346-356. PubMed ID: 36592623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of molecular testing in the diagnosis of thyroid fine needle aspiration cytology: data from mainland China.
    Guo HQ; Zhao H; Zhang ZH; Zhu YL; Xiao T; Pan QJ
    Dis Markers; 2014; 2014():912182. PubMed ID: 24591770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of BRAFV600E mutation analysis and second cytologic review of fine-needle aspiration for evaluating thyroid nodule.
    Kang G; Cho EY; Shin JH; Chung JH; Kim JW; Oh YL
    Cancer Cytopathol; 2012 Feb; 120(1):44-51. PubMed ID: 21751431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of BRAF mutation detection in fine-needle aspiration biopsy samples read as "suspicious for papillary thyroid carcinoma".
    Jara SM; Bhatnagar R; Guan H; Gocke CD; Ali SZ; Tufano RP
    Head Neck; 2015 Dec; 37(12):1788-93. PubMed ID: 24989827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pilot of BRAF mutation analysis in indeterminate, suspicious and malignant thyroid FNA cytology.
    Johnson SJ; Hardy SA; Roberts C; Bourn D; Mallick U; Perros P
    Cytopathology; 2014 Jun; 25(3):146-54. PubMed ID: 24417615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of 54 cases of false-negative fine-needle aspiration among 1347 papillary thyroid carcinomas.
    Proietti A; Borrelli N; Giannini R; Romani R; Di Coscio G; Quilici F; Rago T; Miccoli P; Vitti P; Basolo F
    Cancer Cytopathol; 2014 Oct; 122(10):751-9. PubMed ID: 24913568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung adenocarcinoma and its thyroid metastasis characterized on fine-needle aspirates by cytomorphology, immunocytochemistry, and next-generation sequencing.
    Bellevicine C; Vigliar E; Malapelle U; Carelli E; Fiorelli A; Vicidomini G; Cappabianca S; Santini M; Troncone G
    Diagn Cytopathol; 2015 Jul; 43(7):585-9. PubMed ID: 25900221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allele-specific PCR with competitive probe blocking for sensitive and specific detection of BRAF V600E in thyroid fine-needle aspiration specimens.
    Smith GD; Zhou L; Rowe LR; Jarboe EA; Collins BT; Bentz JS; Wittwer CT; Chadwick BE
    Acta Cytol; 2011; 55(6):576-83. PubMed ID: 22156469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical implication of highly sensitive detection of the BRAF V600E mutation in fine-needle aspirations of thyroid nodules: a comparative analysis of three molecular assays in 4585 consecutive cases in a BRAF V600E mutation-prevalent area.
    Lee ST; Kim SW; Ki CS; Jang JH; Shin JH; Oh YL; Kim JW; Chung JH
    J Clin Endocrinol Metab; 2012 Jul; 97(7):2299-306. PubMed ID: 22500044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.
    Rossi ED; Martini M; Capodimonti S; Lombardi CP; Pontecorvi A; Vellone VG; Zannoni GF; Larocca LM; Fadda G
    Cancer Cytopathol; 2013 Jun; 121(6):291-7. PubMed ID: 23192956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cellularity, genomic DNA yields, and technical platforms for BRAF mutational testing in thyroid fine-needle aspirate samples.
    Dyhdalo K; Macnamara S; Brainard J; Underwood D; Tubbs R; Yang B
    Cancer Cytopathol; 2014 Feb; 122(2):114-22. PubMed ID: 24150898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.